526 related articles for article (PubMed ID: 19383898)
1. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy.
Ader I; Malavaud B; Cuvillier O
Cancer Res; 2009 May; 69(9):3723-6. PubMed ID: 19383898
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
Schnitzer SE; Weigert A; Zhou J; Brüne B
Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia, therapeutic resistance, and sphingosine 1-phosphate.
Cuvillier O; Ader I; Bouquerel P; Brizuela L; Gstalder C; Malavaud B
Adv Cancer Res; 2013; 117():117-41. PubMed ID: 23290779
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells.
Cho SY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Chen CY; Lee EO; Kim SH
J Pineal Res; 2011 Aug; 51(1):87-93. PubMed ID: 21392092
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factors and sphingosine 1-phosphate signaling.
Cuvillier O; Ader I
Anticancer Agents Med Chem; 2011 Nov; 11(9):854-62. PubMed ID: 21707486
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells.
Michaud MD; Robitaille GA; Gratton JP; Richard DE
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):902-8. PubMed ID: 19423865
[TBL] [Abstract][Full Text] [Related]
8. Cellular signalling by sphingosine kinase and sphingosine 1-phosphate.
Leclercq TM; Pitson SM
IUBMB Life; 2006 Aug; 58(8):467-72. PubMed ID: 16916784
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate signalling in cancer.
Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of enzymes for sphingosine 1-phosphate turnover and signaling in human decidua during late pregnancy.
Yamamoto Y; Olson DM; van Bennekom M; Brindley DN; Hemmings DG
Biol Reprod; 2010 Mar; 82(3):628-35. PubMed ID: 20007411
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
Ruckhäberle E; Rody A; Engels K; Gaetje R; von Minckwitz G; Schiffmann S; Grösch S; Geisslinger G; Holtrich U; Karn T; Kaufmann M
Breast Cancer Res Treat; 2008 Nov; 112(1):41-52. PubMed ID: 18058224
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
13. The role of sphingosine kinase and sphingosine-1-phosphate in the regulation of endothelial cell biology.
Limaye V
Endothelium; 2008; 15(3):101-12. PubMed ID: 18568950
[TBL] [Abstract][Full Text] [Related]
14. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
15. New perspectives on the role of sphingosine 1-phosphate in cancer.
Pyne S; Pyne NJ
Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
[TBL] [Abstract][Full Text] [Related]
16. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
Huwiler A; Pfeilschifter J
Biochem Pharmacol; 2008 May; 75(10):1893-900. PubMed ID: 18321471
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase 1/S1P pathway involvement in the GDNF-induced GAP43 transcription.
Murakami M; Ito H; Hagiwara K; Kobayashi M; Hoshikawa A; Takagi A; Kojima T; Tamiya-Koizumi K; Sobue S; Ichihara M; Suzuki M; Banno Y; Nozawa Y; Murate T
J Cell Biochem; 2011 Nov; 112(11):3449-58. PubMed ID: 21769916
[TBL] [Abstract][Full Text] [Related]
18. K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling.
Youm JK; Jo H; Hong JH; Shin DM; Kwon MJ; Jeong SK; Park BD; Choi EH; Lee SH
J Dermatol Sci; 2008 Aug; 51(2):89-102. PubMed ID: 18420384
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase and sphingosine 1-phosphate in asthma.
Lai WQ; Wong WS; Leung BP
Biosci Rep; 2011 Apr; 31(2):145-50. PubMed ID: 21091442
[TBL] [Abstract][Full Text] [Related]
20. Activation of the SPHK/S1P signalling pathway is coupled to muscarinic receptor-dependent regulation of peripheral airways.
Pfaff M; Powaga N; Akinci S; Schütz W; Banno Y; Wiegand S; Kummer W; Wess J; Haberberger RV
Respir Res; 2005 May; 6(1):48. PubMed ID: 15927078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
